Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01888159

Enrollment

100

Registered

2013-06-27

Start date

2013-09-30

Completion date

Unknown

Last updated

2013-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Brief summary

Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation has an effect on ovarian reserve.

Interventions

PROCEDUREBilateral Salpingectomy

PROCEDURETubal sterilization with bipolar energy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 45 Years

Healthy volunteers

Inclusion criteria

* Women seeking for tubal sterilisation

Exclusion criteria

* women older than 45 * family history of ovarian cancer * presence of menopausal symptoms * irregular cycles * Hormone Replacement Therapy or hormone contraceptions the last 3 months * history of previous ovarian or uterine surgeries * imaging suggesting an ovarian cyst or other adnexal pathology during investigation * previous salpingectomy

Design outcomes

Primary

Measure	Time frame
Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)	3 months

Secondary

Measure	Time frame
Anti-Mullerian hormone (AMH)	1 year
Operative time	Postoperatively
Complications	3 months

Other

Measure	Time frame
Follicle Stimulation Hormone (FSH)	3 months

Countries

Sweden

Contacts

Primary ContactLeonidas Magarakis, MD

lemagarakis@gmail.com046737529929

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026